Abstract:
Dibenzothiepin derivatives of the general formula
WHEREIN M, N, R1, R2, R3 and X are as hereinafter set forth, AND SALTS THEREOF AS WELL AS PROCESSES FOR THEIR MANUFACTURE ARE DISCLOSED. The end products are useful as central-depressant and neuroleptic agents.
Abstract:
(+)-CIS-1,3-DIBENZYL - HEXAHYDRO - 1H - FURO(3,4-D)IMIDAZOLE-2,4-DIONE, PREPARED STARTING WITH CIS-1,3-DIBENZYL-HEZAHYDRO-1H-FURO(3,4-D)-IMIDAZOLE - 2,4,6- - TRIONE, IS DESCRIBED. THE END PRODUCT IS A VALUABLE INTERMEDIATE IN THE SYNTHESIS OF (+)-BIOTIN, AS WELL AS DERIVATIVES AND RELATED PRODUCTS THEREOF.
Abstract:
The invention pertains to hydroxymethylimidazodiazepines of general formula (I) and their esters. These compounds can be used as anxiolytic and/or anticonvulsive and/or muscle-relaxing and/or sedative hypnotic agents. In formula (I), A together with the two carbon atoms designated as .alpha. and .beta. is one of the radicals (A1), (A2) or (A3); R1 is hydrogen or lower alkanoyl; R2 is phenyl, o-halophenyl or 2-pyridyl; R3 is hydrogen, lower alkyl, methylaminomethyl, allylaminomethyl or diethylaminomethyl; R4 is halogen, CF3 or nitro; R5 is hydrogen or halogen.
Abstract:
The novel imidazodiazepine derivatives of the general formula in which A, together with the two carbon atoms marked by alpha and beta , denotes one of the groups B denotes one of the radicals Q denotes one of the groups R denotes a lower alkyl group which is optionally substituted by hydroxyl, lower alkoxy, aryl, C3-6-cycloalkyl, aroyl, aryloxy, heteroaroyloxy, acyloxy, aryl-(lower) alkoxy, halogen, the group -NR R or a five-membered heterocycle bonded via a carbon or a nitrogen atom, or denotes a lower alkenyl or alkynyl group, an aroyl group, a five-membered heterocycle bonded via a carbon atom or C3-6-cycloalkyl which is optionally substituted by acyl or lower alkyl, R and R each denote hydrogen, halogen or lower alkyl, R denotes hydrogen or lower alkyl, R denotes hydrogen, aryl, acyl, C3-6-cycloalkyl, aralkoxycarbonyl or lower alkyl which is optionally substituted by aryl, morpholino, lower alkoxy, hydroxyl, 2,2-dimethyl-1,3-dioxolan-4-yl, alkoxycarbonyl, carbamoyl, alkoxycarbonylamino, aralkoxycarbonyl or amino or R and R , together with the nitrogen atom, either denote phthalimido or a six-membered saturated heterocycle, can be used for the control or prevention of diseases. They are particularly suitable for the control or prevention of epileptic attacks, anxiety, tension and excitation states, sleep disorders, schizophrenia symptoms, hepatic encephalopathy and senile dementia, and also partially or completely to antagonise undesired side effects of substances acting on the benzodiazepine receptor after overdosage or after use thereof in intensive medicine and in anaesthesia.
Abstract:
The novel imidazodiazepine derivatives of the general formula in which A, together with the two carbon atoms marked by alpha and beta , denotes one of the groups B denotes one of the radicals Q denotes one of the groups R denotes a lower alkyl group which is optionally substituted by hydroxyl, lower alkoxy, aryl, C3-6-cycloalkyl, aroyl, aryloxy, heteroaroyloxy, acyloxy, aryl-(lower) alkoxy, halogen, the group -NR R or a five-membered heterocycle bonded via a carbon or a nitrogen atom, or denotes a lower alkenyl or alkynyl group, an aroyl group, a five-membered heterocycle bonded via a carbon atom or C3-6-cycloalkyl which is optionally substituted by acyl or lower alkyl, R and R each denote hydrogen, halogen or lower alkyl, R denotes hydrogen or lower alkyl, R denotes hydrogen, aryl, acyl, C3-6-cycloalkyl, aralkoxycarbonyl or lower alkyl which is optionally substituted by aryl, morpholino, lower alkoxy, hydroxyl, 2,2-dimethyl-1,3-dioxolan-4-yl, alkoxycarbonyl, carbamoyl, alkoxycarbonylamino, aralkoxycarbonyl or amino or R and R , together with the nitrogen atom, either denote phthalimido or a six-membered saturated heterocycle, can be used for the control or prevention of diseases. They are particularly suitable for the control or prevention of epileptic attacks, anxiety, tension and excitation states, sleep disorders, schizophrenia symptoms, hepatic encephalopathy and senile dementia, and also partially or completely to antagonise undesired side effects of substances acting on the benzodiazepine receptor after overdosage or after use thereof in intensive medicine and in anaesthesia.